Monthly Archives: August 2017

Arthritis Drug Linked to Heart Failure Doesn’t Warn Patients of Risk

Actemra Arthritis Drug Lawsuits Ohio

In early 2010, the FDA approved the new prescription drug Actemra (tocilizumab) for treatment of severe cases of rheumatoid arthritis. Since then, it has expanded its approval to treatment of moderate RA, giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (PJIA), and systemic juvenile idiopathic arthritis (SJIA). At the time Actemra was initially approved by… Read more »